Improving the MVA Vaccine Potential by Deleting the Viral Gene Coding for the IL-18 Binding Protein

BACKGROUND: Modified Vaccinia Ankara (MVA) is an attenuated strain of Vaccinia virus (VACV) currently employed in many clinical trials against HIV/AIDS and other diseases. MVA still retains genes involved in host immune response evasion, enabling its optimization by removing some of them. The aim of...

Descripción completa

Detalles Bibliográficos
Autores principales: Falivene, Juliana, Del Médico Zajac, María Paula, Pascutti, María Fernanda, Rodríguez, Ana María, Maeto, Cynthia, Perdiguero, Beatriz, Gómez, Carmen E., Esteban, Mariano, Calamante, Gabriela, Gherardi, María Magdalena
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3285208/
https://www.ncbi.nlm.nih.gov/pubmed/22384183
http://dx.doi.org/10.1371/journal.pone.0032220

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3285208/
https://www.ncbi.nlm.nih.gov/pubmed/22384183
http://dx.doi.org/10.1371/journal.pone.0032220

Ejemplares similares